chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. No pertinent medical history was reported. On an unknown dates between 01-SEP-2015 and 09-SEP-2015, the patients were vaccinated with MMR II (lot # J013131 and expiration date 17-OCT-2015, lot# J013431 and expiration date 24-OCT-2015, lot# K024825 and expiration date 02-DEC-2016) (dose and route were not reported) that were improperly stored. No adverse effects reported. No Product Quality Complaint (PQC) was involved. This is one of the several reports received from the same source. Additional information has been requested.
This spontaneous reports as received from an office manager refers to unspecified patients of unknown age and gender. Pertinent medical history, drug reactions or allergies were not reported. On 22-APR-2014, the patients were vaccinated with improperly stored PNEUMOVAX23, reported lot# J013555 expiry date: 02-MAY-2015 (dose was not reported) that had been received outside recommended shipping duration. No adverse effects reported. Additional information has been requested.
At midnight (about 7 hours after flu shot given) developed hives, itchy throat, shortness of breath. Took 6 doses of oral BENADRYL at home, then went to ER because not improving.
Received Expired Dose of Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine). On 25-May-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information was provided by the reporter.  No treatment information was provided.
Fever, chills, severe nonstop headache, including my entire face, nausea, complete body ache, fatigue, weakness, sudden sweating and severe nausea, extreme weakness disableing my ability to walk upright to even get to the bathroom.  This lasted 3 days 03/16/2021 through 03/18/2021.  Sever symptoms decreased to managable levels by 03/19/2021, except for off and on nausea.   Fatigue, lack of energy and weakness still remain as of the report 03/23/2021
Information had been received on 26-MAY-2017 from a lawyer regarding a case in litigation. The patient's medical history, concurrent conditions and concomitant medication were not provided. It was alleged in litigation that a female patient of unknown age was inoculated with ZOSTAVAX (dose, route, site of administration, lot # and expiration date were not provided) on or about 05-FEB-2009 at a clinic, as recommended for routine adult health maintenance for the prevention of shingles. The lawyer reported, the ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of Herpes Zoster. On or about 12-MAR-2015, the patient was treated at clinic for a vesicular outbreak that was diagnosed as severe shingles. On or about 24-MAY-2016 the female patient was further diagnosed with post herpetic neuralgia, a secondary condition to shingles that involves residual and chronic nerve pain. As a direct and proximate result of these malfunctions, patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
Patient stated she was having heart palpitations and SOB. She was taken to the ED and all tests were normal, no palpitations and oxygen sats were in the normal range. Anxiety attack.
weird taste in mouth; pain and swelling in armpit; pain and swelling in armpit; Fatigue; extreme joint and muscle pain; extreme joint and muscle pain; congestion; This is a spontaneous report from a non-contactable consumer (patient). A 51-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number and Expiry date were not reported) via an unspecified route of administration on 20Apr2021 09:30 as dose 2, single for COVID-19 immunization. The patient medical history included allergic to artichokes from an unknown date and unknown if ongoing. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, batch/Lot Number and Expiry date was not reported) via an unspecified route of administration on an unspecified date at 09:30 on an unspecified date in Mar2021 for COVID-19 immunization and experienced menstrual period after first injection more painful. The patient reported had not diagnose with COVID-19 prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not tested for COVID-19. On 20Apr2021, the patient experienced fatigue, extreme joint and muscle pain, and congestion. On 22Apr2021, patient experienced pain and swelling in armpit, and weird taste in mouth on 23Apr2021. No treatment was taken for the events. The outcome of the events was reported as recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
patient experienced swollen and rash at injection site.  Patient spoke with her Dr., Dr and was advise to take benadryl.  Patient appear to be normal at the time of appointment for the second dose of Moderna vaccination.  Patient was adviced by her Dr. to take Benadryl to treat her adverse reaction for the second dose if occurred.
Received flu vacc on 9-8-2014. (First ever) soon after had swelling and severe pain in the (L) deltoid triceps muscle at injection site. Indurated soft tissue is still tender and worsening severe pain. Referred to P.T.
Arm was actually sore starting the evening that the vaccine was administered.  Continued to be sore but didn't notice the severe erythema swelling until the morning of 8/5.
Pt given combo vaccine of Dtap/IPV. Pt contacted. No adverse s/s reported by pt.
diffuse lower extremity rash, which worsened over the span of months .  Blisters and serous drainage.
I received my third vaccine, a booster shot, and my life took a significant and dramatic downward negative turn concerning my physical health. I developed chronic, debilitating  headaches.  I was diagnosed with asthma.  I was diagnosed with multiple nodules on my thyroid and told I had Graves disease.  I now have an inflamed bladder that causes frequent urination- 20 times a day.  I also suffer from joint pain in my hands and feet, as well as a stiff neck.  I have seen 10 doctors and a physical therapist in the last nine months.  I am presently on several medications and have experienced minimal improvement.  My doctors and I firmly believe that these symptoms are the result of a serious ?vaccine injury?.
tested positive for covid; This is a spontaneous report from a contactable consumer (parent). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; via an unspecified route of administration on 11Apr2021 Batch/Lot number was not reported) as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient tested positive for covid, six days later on 17Apr2021. She was told that she needs to wait to receive her second dose. In the interim she moved from one place (where she received her first dose) to other state. Caller reported that she thought her daughter had some lingering effects. She had been told different things, that she should receive the second dose and she need to start the series over. Caller asked for clarification. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 17Apr2021. The outcome of the event was unknown.  The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.
Some fluid leaked on arm; Some fluid leaked on arm; A spontaneous report was received from a physician, concerning herself, a 42-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and some fluid leaked on arm.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On an unspecified date, the patient received their first of two planned doses of mRNA-1273 (Batch number not provided). On 04 Feb 2021, the patient received their second of two planned doses of mRNA-1273 (Batch number: 028L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection and some fluid leaked on her arm.   No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.  The event, some fluid leaked on her arm, was considered resolved on 04 Feb 2021.; Reporter's Comments: This report refers to a case of product administration error for mRNA-1273 (Batch number: 028L20A). There was no associated AEs with this case of inappropriate dose administered and exposure via skin.
pain & swollen lymph node on left armpit 1 day aftr booster dose,lasted 3 days.tylenol didnt help.body pains on 5th day & a bit swollen lymph node on right groin.reported to employee health clinic & told to go home & get tested for covid.symptoms improving on 6th day today
Patient fainted 5 minutes after receiving her 1st Covid pfizer vaccine. Her mother caught her. She was given water and sat down for an additional 30 mins. She had no other symptoms other than fainting.
had a cold; fever; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (had a cold) and PYREXIA (fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (had a cold) and PYREXIA (fever). The patient was treated with PREDNISONE for Adverse reaction, at a dose of 20mg in a 5 days cycle and TETRACYCLINE for Adverse reaction, at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (had a cold) outcome was unknown and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.   Reporter did not allow further contact
No side effects reported.; patient was administered VAXNEUVANCE and ROTATEQ after they experienced a supported temperature excursion.; This spontaneous report was received from a medical assistant referring to a patient of unspecified age and gender. Information regarding the patient's medical history, concurrent conditions, concomitant therapies and previous drug reactions or allergies were not reported.   On 09-AUG-2023,  the patient was administered an improperly stored dose of pneumococcal 15v conj vaccine (CRM197) (VAXNEUVANCE) 0.5 milliliters (mL) (route of administration was not reported; lot number X004289 has been verified to be valid, expiration date reported and established as 10-DEC-2024), and an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 2 mL administered orally (lot number W036404 has been verified to be valid, expiration date reported and established as 24-APR-2024); both administered as prophylaxis.  The vaccines were exposed to a temperature excursion of 11.2 degrees Celsius during a time frame of 2 hours and 36 minutes (product storage error). There was no previous temperature excursion.   No side effects were reported (no adverse event).
CHILLS; MUSCLE ACHES; This spontaneous report received from a parent concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, and batch number: 203A21A expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced muscle aches. On 13-APR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills and muscle aches was not reported. This report was non-serious.
very sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (very sore arm) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (very sore arm). At the time of the report, PAIN IN EXTREMITY (very sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient took concomitant medications of Antidepressants. No treatment medications were provided by reporter.   This case was linked to MOD-2021-306642 (Patient Link).
Have been down and out of my daily routine all week. Was uncontrollably vomiting, and running a fever of 101.2. Had a migraine for days straight. The sight of lights and even medication would not help. Took Tylenol and Motrin. Had troubles eating due to vomiting. I was severely dehydrated and sick for 4-5 days.
pt recv vax 2MAR97 & 23NOV97 pt exp chickenpox w/40 lesions;
Patient had complaints of dizziness, being unsteady on her feet, elevated blood sugar, and increased confusion.  While at dialysis she developed worsening confusion and change in LOC and running temp.  She was sent to the ER
This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and drug reactions/allergies were not provided. On 30-NOV-2017, the patient was vaccinated with improperly stored doses of VARIVAX (lot# N019127, expiration date: 22-JUN-2019) and GARDASIL 9 (lot# N012093, expiration date: 13-JAN-2020), both for prophylaxis, route of administration and doses were not reported. Concomitant medications included sterile diluent (MERCK STERILE DILUENT) (lot# N001534, expiration date: 30-JUL-2019) used to reconstitute improperly stored VARIVAX; it was unspecified if the sterile diluent (MERCK STERILE DILUENT) was properly stored. No adverse effects were reported. The temperature exposure was reported as follows: VARIVAX (lot# N019127, expiration date: 22-JUN-2019) underwent a temperature below 32°F for 1 hour, and 47°F to 77°F for 2 hours, with no previous temperature excursion. Digital data logger was involved. GARDASIL 9 (lot# N012093, expiration date: 13-JAN-2020) underwent a temperature of 15°F to 46°F for 1 hour 30 minutes, and 47°F to 77°F for 2 hours, with no previous temperature excursion. Digital data logger was involved. Subsequently, the nurse called back on 14-DEC-2017 and clarified that the GARDASIL 9 was not improperly stored and confirmed that no adverse effects were involved; so GARDASIL 9 was assessed as a concomitant vaccine.
A large bump appeared, rash appeared at injection site, injection warm at touch, numbness in hands.
Initial unsolicited report received from consumer (patient himself) on 16-Oct-2017. This case involves a male patient (age not reported) who was vaccinated with 0.5 ml two doses of FLUZONE HIGH-DOSE (Batch numbers, expiry date, dose in series were not reported) intramuscularly in right arm on an 01-Oct-2015 and on an unknown date for the past two years. The patient's medical history and concomitant medications were not reported. On unknown date, after the vaccination with two doses of FLUZONE HIGH-DOSE, patient developed muscle weakness, aches, started in right shoulder both times and eventually extended to legs, patient reported that it got to the point he was almost unable to care for himself and any movement caused severe pain. It was reported as the patient did not received flu shot this year, because his right arm was still pretty painful. Laboratory investigations were not reported. It was reported as a corrective treatment patient received treatment from physician with some sort of shot in to his right arm and pills, that he had to take for 5 days. On an unknown date, patient recovered from all the events. List of documents held by sender: none.
I had sore throat, headache off and on, very low energy, chills and body ache. I wake up with sweating.
Information has been received from a licensed practical nurse concerning 2 patients of unknown age and gender. The patients' concurrent conditions and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of (Oka/Merck) VARIVAX (lot# J013904, expiry date 30-OCT-2015; dose and route of administration were not reported). Additional information is not expected as all the schedule correspondence has been obtained. This is one of several reports from the same reporter.
Day 1 No adverse affect.  Day 2 about 7:15 pm  suddenly pounding heart and panting to breath.  Fitbit showed HR of 134.  Weak.  Layed down.  Took extra Propanolol.  Stopped after 5-10 minutes.  Scary.  Took BP and it was 175/89.  Felt warm while sleeping poorly.  Got up and BP was 105/40.  Temp was 99.   Fell asleep.  Felt poorly all day but fine on Day 3
Breakthrough case admission after 2 vaccines Pfizer 3/11/21 Lot# EN6199;  Pfizer 4/1/21 Lot# ER8733
Migraine; Dizziness; Headache; This is a spontaneous report from a contactable consumer (Patient). A 52-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0186), via an unspecified route of administration, administered in Arm Right on 14May2021 (at the age of 52-year-old) as dose 1, single for covid-19 immunisation. Medical history included anxiety from an unknown date and unknown if ongoing, hypothyroidism from an unknown date and unknown if ongoing, allergy to artificial sugars. Concomitant medications included celecoxib (CELEXA) taken for an unspecified indication, start and stop date were not reported; topiramate (TOPAMAX) taken for an unspecified indication, start and stop date were not reported; levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported. On 16May2021, the patient experienced migraine, dizziness, headache. Patient was not informed about the vaccine containing artificial sugars and she mentioned that she is allergic to all types of artificial sugars. When asked for side effects, consumer stated, "Yes, I get migraines from the artificial sugars and I have been suffering from the migraine since I got the shot along with the dizziness but I don't know it's just a typical side effect of the shot but yeah I have been getting migraine". Consumer stated, "It's probably, I would say may be 16May, I don't think I got the headache right away but on 16 definitely it went really bad." The patient underwent lab tests and procedures which included full blood count: unknown date. Therapeutic measures were taken as a result of events included maxalt. The outcome of the events were unknown.   Information on Lot/Batch number was available. Additional information has been requested
CLIENT BECAME PALE IN COLOR AFER 10 MINUTES-ALSO STARTED FEELING AMD SKIN WET TO TOUCH- INITIAL BP/135/100- PULSE 1---02 SAT 99-OFFERED WATER-BECAME NAUSEATED AND NOTED B/P-126/88 P.64 (9:20)-GIVEN ADDITIONAL 30  NINUTES TO COOL BPDY DOWN- NEVER ;LOST CONSCIOUS- ALSO GIVEN INSTRUSTION TO HOME AND CONTINUE HYDRATION AND NOTIFY DOCTOR IF SYMPTOMS BECP,E WORST- ASSISTED BY EMTS-
Extreme fatigue, muscle pain, headache. Difficulty getting out of bed. Slept 23 hours a day for 6 days. Increasing muscle pains for 3 weeks.
The pt experienced a red rash for 2 days, fever, decreased appetite, decreased liquids were also experienced.
Spontaneous nosebleed 2hours after injection; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207), via an unspecified route of administration in the left arm on 23Mar2021 at 16:45 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. The patient did not have any medical history at the time of report. Concomitant medications included low dose acetylsalicylic acid (ASPIRIN), multivitamin and flaxseed oil, all for unknown indication within two weeks of vaccine. The patient did not have any allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 23Mar2021 at 18:45, the patient experienced spontaneous nosebleed 2 hours after injection. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event nosebleed was resolving.  No follow-up attempts are needed. No further information is expected.
Expired vaccine administered to 10 patients (Patient 10 out of 10). No adverse events reported at all; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 10 patients (Patient 10 out of 10). No adverse events reported at all) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 10 patients (Patient 10 out of 10). No adverse events reported at all). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 10 patients (Patient 10 out of 10). No adverse events reported at all) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  A nurse injected expired Moderna COVID-19 vaccine to 10 patients on 23-Feb-2022. Vaccines were stored at normal refrigerated temperature range 38F to 40F. Date the vial was moved from freezer to refrigerator was on 24-Jan-2022. Vial location was in a nursing home and reporter was not sure if they discarded the vial or they still have it in the refrigerator. Visual inspection noting any vaccine state change was no abnormality reported. Total number of vials/doses impacted were 1 vial = 7.5 ml (14 dose each), only 10 doses administered (9 booster and 1 second dose).  No treatment information was provided.